Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

State accuses radiologist of overlooking brain aneurysm that killed 44-year-old patient

Authorities leveled the accusation in an administrative complaint filed last month against Mark A. McGehee, MD. 

maya kowalski case

Clinical decision support significantly reduces use of CT for pulmonary embolism

Across  340,000 hospital admissions, there was a 7.4% decrease in CTPA use after referrers started consulting CDS, experts write in JACR

Trinity Health Muskegon Hospital

Radiology vendor Visage Imaging scores $210M deal with large hospital system

The enterprise imaging deal is with 93-hospital Trinity Health, which wants to transition from nine legacy PACS to one unified system. 

artificial intelligence AI healthcare

Industry Watcher’s Digest

IT departments are budgeting more for AI in 2025 than for any other single area of investment. 

Ransomware Cyberattack Data Breach

Cryo-frozen tissue manufacturer suffers cyberattack

In an SEC filing, Artivion did not provide a lot of specifics. However, the incident appears to be a ransomware attack. 

artificial intelligence AI in healthcare

Stanford HAI lookback: Best-read blog posts of 2024

The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.

RSNA Board member Richard Heller, MD, explains issues with Medicare reinburements and the No Surprises Act and Congressional actions that may fix both.

Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Artivion, an Atlanta-based medical device company, has received a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its AMDS Hybrid Prosthesis designed to treat DeBakey Type 1 dissections when malperfusion occurs. This HDE ensures select patients can be treated with the device before the FDA makes its final approval decision.

First surgical device of its kind granted key FDA exemption

This update helps ensure Artivion's AMDS Hybrid Prosthesis can be used to treat high-risk patients as the FDA makes its final approval decision. The news came as Artivion works to bounce back from a cybersecurity attack that occurred in November.